Defense Health Care:

Pharmacy Copayments

HEHS-99-134R: Published: Jun 8, 1999. Publicly Released: Jun 8, 1999.

Additional Materials:


Stephen P. Backhus
(202) 512-7111


Office of Public Affairs
(202) 512-4800

Pursuant to a congressional request, GAO responded to concerns regarding its previous recommendations proposing that Department of Defense (DOD) pharmacy programs charge copayments for prescription drugs.

GAO noted that: (1) the recommendations in GAO's report were designed to correct serious problems in DOD's pharmacy benefit programs and at the same time enable a more flexible and richer benefit package at the lowest possible cost; (2) GAO believes that the introduction of incentive-based copayments is an essential element in the overall plan to provide stable, high-quality pharmacy benefits over the long term; and (3) Medicare-eligible retirees should be better off with a pharmacy benefit that covers the drugs they need with a reasonable copayment compared with a copayment-free benefit that does not include many of those drugs.

Mar 1, 2021

Feb 24, 2021

Feb 17, 2021

Feb 11, 2021

Feb 5, 2021

Jan 28, 2021

Jan 21, 2021

Looking for more? Browse all our products here